[HTML][HTML] The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro

X Wang, A Elksnis, P Wikström, E Walum, N Welsh… - PLoS …, 2018 - journals.plos.org
It has been proposed that pancreatic beta-cell dysfunction in type 2 diabetes is promoted by
oxidative stress caused by NADPH oxidase (Nox) over-activity. The aim of the present study …

The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro

X Wang, A Elksnis, P Wikström, E Walum, N Welsh… - PLoS ONE, 2018 - hero.epa.gov
It has been proposed that pancreatic beta-cell dysfunction in type 2 diabetes is promoted by
oxidative stress caused by NADPH oxidase (Nox) over-activity. The aim of the present study …

The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro

X Wang, A Elksnis, P Wikstrom, E Walum, N Welsh… - PLoS ONE, 2018 - go.gale.com
It has been proposed that pancreatic beta-cell dysfunction in type 2 diabetes is promoted by
oxidative stress caused by NADPH oxidase (Nox) over-activity. The aim of the present study …

The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro

X Wang, A Elksnis, P Wikström, E Walum… - PloS …, 2018 - pubmed.ncbi.nlm.nih.gov
It has been proposed that pancreatic beta-cell dysfunction in type 2 diabetes is promoted by
oxidative stress caused by NADPH oxidase (Nox) over-activity. The aim of the present study …

[引用][C] The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro

X Wang, A Elksnis, P Wikström, E Walum… - PLoS …, 2018 - ui.adsabs.harvard.edu
The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell
death in vitro - NASA/ADS Now on home page ads icon ads Enable full ADS view NASA/ADS …

[HTML][HTML] The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro

X Wang, A Elksnis, P Wikström, E Walum, N Welsh… - PLoS ONE, 2018 - ncbi.nlm.nih.gov
It has been proposed that pancreatic beta-cell dysfunction in type 2 diabetes is promoted by
oxidative stress caused by NADPH oxidase (Nox) over-activity. The aim of the present study …

The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro.

X Wang, A Elksnis, P Wikström, E Walum, N Welsh… - Plos one, 2018 - europepmc.org
It has been proposed that pancreatic beta-cell dysfunction in type 2 diabetes is promoted by
oxidative stress caused by NADPH oxidase (Nox) over-activity. The aim of the present study …

The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro.

X Wang, A Elksnis, P Wikström, E Walum… - PLoS …, 2018 - search.ebscohost.com
It has been proposed that pancreatic beta-cell dysfunction in type 2 diabetes is promoted by
oxidative stress caused by NADPH oxidase (Nox) over-activity. The aim of the present study …

[PDF][PDF] The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro

X Wang, A Elksnis, P Wikström, E Walum, N Welsh… - PLoS ONE, 2018 - scholar.archive.org
It has been proposed that pancreatic beta-cell dysfunction in type 2 diabetes is promoted by
oxidative stress caused by NADPH oxidase (Nox) over-activity. The aim of the present study …

[PDF][PDF] The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro

X Wang, A Elksnis, P Wikström, E Walum… - PLoS …, 2018 - pdfs.semanticscholar.org
It has been proposed that pancreatic beta-cell dysfunction in type 2 diabetes is promoted by
oxidative stress caused by NADPH oxidase (Nox) over-activity. The aim of the present study …